Honestly guys I'm well invested in this company and believe in the upside. If a commercial deal comes next week .
However this science is still a way off commercialisation.
Dont these two sentences contradict eachother?
The commercial deal about to be announced (we think) has nothing to do with gvhd ...and msb's announced price for the treatment is 100k dollars plus.
Our loi's are based on the supply of ipsc derived mscs...ready for commercialisation now.
Wen customers start to sign on with us ,their 100k price tag will probably come down to 5 to 10k..useable by everyone...
Cymerus makes msc pricing a mass market product...and its commercially ready now.
As i suspect we are about to read very very soon.
The Life Sciences Report, page-48
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
-0.005(2.44%) |
Mkt cap ! $36.11M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 20.0¢ | 19.0¢ | $19.42K | 101.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8208 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 9829 | 1 |
View Market Depth
| Last trade - 15.42pm 03/09/2024 (20 minute delay) ? |
| CYP (ASX) Chart |